Bayer To Highlight Full Menu Of Centaur Hepatitis Automated Assays At AACC
This article was originally published in The Gray Sheet
Executive Summary
Bayer Diagnostics will unveil clinical trial data from a PMA submission for two recently approved hepatitis B assays at the American Association for Clinical Chemistry annual meeting in Orlando July 24-28
You may also be interested in...
Bayer Nabs Approval For “Fully Automated” HIV Antibody Test
Bayer is stressing the productivity advantages of its newly approved EHIV diagnostic, which the company says is the first fully automated antibody test for HIV
Bayer Nabs Approval For “Fully Automated” HIV Antibody Test
Bayer is stressing the productivity advantages of its newly approved EHIV diagnostic, which the company says is the first fully automated antibody test for HIV
Bayer Diagnostics launches compact Centaur
The firm announces FDA clearance for the Advia Centaur CP immunoassay system Nov. 21. The CP system takes up less than half the floor space as the Advia Centaur, making it appropriate for satellite and mid-sized labs, Bayer says. The platform can process 180 tests per hour, including cardiovascular, oncology, fertility and infectious disease assays. Bayer increased its total number of automated hepatitis tests to eight with the approval of two hepatitis B assays in May (1"The Gray Sheet" July 11, 2005, p. 12)...